KELOWNA, BC, Dec. 16, 2021 /CNW/ – Klonetics Plant Science Inc received its Nursery Cultivation licence to produce cannabis starting materials available for sale to the cannabis industry in Canada in June 2021. Operating out of an impressive 25,000 Square Foot state of the art facility in Kelowna, Klonetics produces Ready to Flower plants at an industrial scale for Canadian licensed producers and has the capability …
BALTIMORE, Dec. 16, 2021 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics is pleased to announce that its strategic advisor and developer of GCANRx’s licensed cannabinoid therapeutic, Dr. Adi Aran, M.D., will be interviewed as a world-renowned thought leader and pioneer in cannabis research on CNN’s Award-winning Series …
Long Beach, CA, Dec. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Cannabis Science Conference, the world’s largest and fastest growing cannabis science event, announced the launch of its first-ever Sunshine State event in Long Beach, California, at the Long Beach Convention and Entertainment Center on Feb. 2 through Feb. 4 with an interactive, pre-conference Canna Boot Camp event Feb. 2. The …
REDWOOD CITY, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company with operations in cannabis production and distribution as well as pharmaceutical research and development, announced today that the Company is currently seeking qualified participants for their WCG IRB (Puyallup, WA)-approved cannabis …
Ottawa, Canada: Surgery patients with a history of moderate cannabis use are no more likely to experience adverse perioperative outcomes than are those with no history of use, according to data presented at the 2021 Meeting of the American Society of Regional Anesthesia and Pain Medicine. Canadian researchers assessed surgical outcomes among a cohort of cannabis users and non-users at a single institution over a …
Bern, Switzerland: The inhalation of CBD-dominant cannabis flowers does not influence subjects’ reaction time, concentration, balance, time perception, or other skills associated with driving ability, according to data published in the journal Forensic Sciences Research. A team of Swiss researchers assessed the influence of either CBD-dominant cannabis (16.6 percent CBD and 0.9 percent THC) or placebo on a variety of neurocognitive and psychomotor skills. …
San Juan, Puerto Rico: More than a quarter of patients diagnosed with Inflammatory Bowel Disease report having used cannabis therapeutically, according to survey data published in the Puerto Rico Health Sciences Journal. A team of investigators affiliated with the University of Puerto Rico School of Medicine surveyed IBD patients about their use of medical marijuana. Medical cannabis products are legal in Puerto Rico for patients with …
Los Angeles, CA: The use of either herbal cannabis or medicines containing plant-derived cannabinoids is associated with significant reductions in patients’ neuropathic pain, according to a review of placebo-controlled clinical trial data published in the Journal of Dental Anesthesia and Pain Medicine. Researchers with the University of Southern California reviewed data from 17 placebo-controlled clinical trials involving 861 neuropathic pain patients. Patients in the …
ARVADA, Colo.–(BUSINESS WIRE)–Colorado-based technology company Boulder Creek Technologies today announced new nationwide availability for its revolutionary Vapor-Static Extraction system. This sustainable system applies proven industrial processes to large-scale cannabinoid extraction that reduces operating costs by 80% over contemporary extraction methods. Vapor-Static Extraction provides a turnkey solution for manufacturing distillation-ready concentrates by utilizing an all-in-one, continuous process for operators to convert biomass to …
CARSON CITY, NV, Dec. 09, 2021 (GLOBE NEWSWIRE) — Pharmagreen Biotech, Inc., (OTC PINK: PHBI), today released a second management update form CEO Peter Wojcik. Today’s update provides further information on the company’s strategy to convert the revenue potential of its proprietary intellectual property into realized revenue. The first update can be reviewed and the following link: Pharmagreen Taps Revenue …